Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial
暂无分享,去创建一个
J. Cuzick | K. Byth | M. Dowsett | J. Graham | C. Clarke | I. Šestak | P. Forgez | A. Gompel | D. Hugol | P. Mote | C. Howe | H. Hilton | Christine L. Clarke | Heidi N. Hilton